Specialty Oncology
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Biomarker-Driven Cancer Care Is Not Reaching All Americans
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0920Published: September 2020Expires: 9/2/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Specialties: Advanced Practice Nursing, OncologyTopics: Biomarker -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Cancer Immunotherapy Paves the Way for Better Understanding of COVID-19
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0820Published: August 2020Expires: 7/3/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Specialties: Advanced Practice Nursing, OncologyTopics: COVID-19 , Immunotherapy -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Three Myeloproliferative Neoplasms: An Overview
Price: $17.95Credits:
- ANCC 1.5 CH
- DC - BON 1.5 CH
- FL - BON 1.5 CH
- GA - BON 1.5 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: N0820APublished: Aug 2020Expires: 9/2/2022Sources: Nursing2020DetailsRequired Passing Score: 13/18 (72%) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Androgen Deprivation Therapy Could Protect Men Against COVID-19
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0720Published: July 2020Expires: 6/3/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Specialties: Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Genomic Sequencing Initiative Advances Angiosarcoma Research
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0620Published: June 2020Expires: 6/3/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Topics: Angiosarcoma , Genomics -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Paget's Disease of the Breast Presenting as Nipple Ulceration With Normal Mammogram
Price: $20.00Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: JDNA0520BPublished: May/Jun 2020Expires: 6/3/2022DetailsRequired Passing Score: 7/10 (70%)Topics: Paget's Disease -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Rising Role of the Microbiome in Cancer
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0520Published: May 2020Expires: 3/4/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Specialties: Advanced Practice Nursing, OncologyTopics: Microbiome -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Slows Progression in Refractory HER2+ Breast Cancer
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0420Published: April 2020Expires: 3/4/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%) -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Antibody Drug Conjugates: New Weapons Against Cancer
Price: $12.95Credits:
- ANCC 1.0 CH
- DC - BON 1.0 CH
- FL - BON 1.0 CH
- GA - BON 1.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0320Published: March 2020Expires: 3/4/2022Sources: Oncology TimesDetailsRequired Passing Score: 7/10 (70%)Categories: Advanced Practice Nursing , OncologySpecialties: Advanced Practice Nursing, Oncology -
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Current Evidence Related to Intermittent Catheterization: A Scoping Review
Price: $21.95Credits:
- ANCC 2.0 CH
- DC - BON 2.0 CH
- FL - BON 2.0 CH
- GA - BON 2.0 CH
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: JWOCN0320APublished: Mar/Apr 2020Expires: 3/4/2022DetailsRequired Passing Score: 14/19 (73%)Categories: Evidence Based Practice , GenitourinarySpecialties: Continence, Oncology